United States · General news · The Boston Globe
Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives
The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met by approved name-brand drugs.
Read the full article on The Boston Globe Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bostonglobe.com)




